FDA Inspection 1251530 — Apothecus Pharmaceutical Corp.

Apothecus Pharmaceutical Corp. — FEI 3001746542

The FDA completed an inspection of Apothecus Pharmaceutical Corp. on November 15, 2024 in Hicksville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 15, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hicksville, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
126321 CFR 211.68(b)Computer control of master formula records
135821 CFR 211.100(b)SOPs not followed / documented
154021 CFR 211.125(a)Strict control not exercised over labeling issued
202721 CFR 211.192Investigations of discrepancies, failures
438921 CFR 211.198(a)Procedures to be written and followed